Global Evidence on Assuring Quality of Medicines

Huma Rasheed; Rabia  Khokhar; Raffaella Ravinetto; Zaheer-Ud-Din  Babar

doi:10.1007/978-3-030-50247-8

Global Evidence on Assuring Quality of Medicines

Huma Rasheed
, Rabia Khokhar
, Raffaella Ravinetto
, Zaheer-Ud-Din Babar

Research output: Chapter in Book/Report/Conference proceeding › Contribution to book/anthology › peer-review

Abstract

Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

Original language	English
Title of host publication	Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
Number of pages	15
Place of Publication	Switzerland
Publisher	Springer
Publication date	2023
Pages	1-15
ISBN (Print)	978-3-030-50247-8
ISBN (Electronic)	978-3-030-50247-8
DOIs	https://doi.org/10.1007/978-3-030-50247-8
Publication status	Published - 2023

Keywords

B740-pharmacy
B680-public-health

Access to Document

10.1007/978-3-030-50247-8

Cite this

@inbook{df1423a097dc4dcd9e9e7363ca3a69bc,

title = "Global Evidence on Assuring Quality of Medicines",

abstract = "Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.",

keywords = "B740-pharmacy, B680-public-health",

author = "Huma Rasheed and Rabia Khokhar and Raffaella Ravinetto and Zaheer-Ud-Din Babar",

year = "2023",

doi = "10.1007/978-3-030-50247-8",

language = "English",

isbn = "978-3-030-50247-8",

pages = "1--15",

booktitle = "Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy",

publisher = "Springer",

address = "Germany",

}

TY - CHAP

T1 - Global Evidence on Assuring Quality of Medicines

AU - Rasheed, Huma

AU - Khokhar, Rabia

AU - Ravinetto, Raffaella

AU - Babar , Zaheer-Ud-Din

PY - 2023

Y1 - 2023

N2 - Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

AB - Quality of medicine is a major challenge, especially in low- and middle-income countries. The factors contributing include weak regulatory capacity, the capacity of the pharmaceutical industry, supply chain issues, and technical manpower. This chapter presents the global research evidence related to the quality of medicines. This is presented in the form of reviews and research studies published on the topic. The chapter illustrates the global scenario regarding substandard and falsified medicines. The approaches to medicines testing are also discussed including field testing, visual inspection as well as the role of information technology. Consumer education about substandard and falsified medicines is also being discussed. The chapter concludes that the quality of medicines and other health products is a key healthcare concern, and it needs to be dealt with through a multistakeholder engagement process.

KW - B740-pharmacy

KW - B680-public-health

UR - https://link.springer.com/referenceworkentry/10.1007/978-3-030-50247-8_112-1#chapter-info

U2 - 10.1007/978-3-030-50247-8

DO - 10.1007/978-3-030-50247-8

M3 - Contribution to book/anthology

SN - 978-3-030-50247-8

SP - 1

EP - 15

BT - Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy

PB - Springer

CY - Switzerland

ER -

Global Evidence on Assuring Quality of Medicines

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this